Clal Biotechnology | CBI - EPS Earnings Per Share


Clal Biotechnology reported ILS-0.04 in EPS Earnings Per Share for its fiscal quarter ending in December of 2022.





Eps Change Date
Arca Biopharma USD -0.5 0.08 Mar/2025
aTyr Pharma USD -0.26 0.05 Sep/2025
Bio Path USD -0.4 0.33 Mar/2025
Brainstorm Cell Therapeutics USD -0.45 0.06 Mar/2025
Cara Therapeutics USD -5.04 3.24 Dec/2024
Clal Biotechnology ILS -0.04 0.1 Dec/2022
Compugen USD -0.08 0 Sep/2025
Immunic USD -0.24 0.03 Sep/2024
Infinity Pharmaceuticals USD -0.11 0.01 Jun/2023
Minerva Neurosciences USD -0.56 3.53 Dec/2024
RedHill Biopharma USD -1.31 33.38 Jun/2024
TherapeuticsMD USD -0.09 0.02 Jun/2024